National Association of Home Builders Names Bridgeland® Master Planned Community of the Year for 2024
March 04, 2024 07:17 ET
|
Howard Hughes Holdings Inc.
The community of Bridgeland® has been named “Master Planned Community of the Year” by the National Association of Home Builders (NAHB).
BTSE deploys Fireblocks’ custody solutions to augment digital asset management
April 27, 2023 09:30 ET
|
BTSE Holdings Limited
ROAD TOWN, British Virgin Islands, April 27, 2023 (GLOBE NEWSWIRE) -- BTSE, a leading digital asset exchange, today announced that it has collaborated with the digital asset custody and transfer...
Next Block Expo veranstaltet ihre erste Web3-Konferenz in Berlin; Aleph Zero, Ethereum Foundation, Binance Academy und Polygon unter den bestätigten Partnern
November 14, 2022 08:15 ET
|
Aleph Zero
ZUG (Schweiz), Nov. 14, 2022 (GLOBE NEWSWIRE) -- WANN23. und 24. November 2022 WOStation Berlin, Luckenwalder Str. 4-6, 10963 Berlin, Deutschland WASAleph Zero freut sich, bekanntgeben zu...
Next Block Expo Hosts the First Edition of its Web3 Conference in Berlin; Aleph Zero, Ethereum Foundation, Binance Academy, and Polygon among confirmed partners
November 14, 2022 08:15 ET
|
Aleph Zero
ZUG, Switzerland, Nov. 14, 2022 (GLOBE NEWSWIRE) -- WHENNovember 23 - 24, 2022 WHEREStation Berlin, Luckenwalder Str. 4-6, 10963 Berlin, Germany WHATAleph Zero is proud to announce that it is...
Leonovus Announces a New Product - XVault
February 23, 2021 08:01 ET
|
Leonovus Inc
OTTAWA, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Leonovus Inc., ("Leonovus" the "Company") (TSXV: LTV) today announces the beta launch of a new product called XVault. The Company is looking for beta...
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
October 08, 2018 02:00 ET
|
Akers Biosciences Inc
THOROFARE, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...
Type 2 Diabetes Trial Results Published In Diabetes Care
July 22, 2015 19:17 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, July 22, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; USOTC: MBLTY) today announced that results of the Phase 2 trial of its intravenously-delivered...